These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 35279121

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
    Sasaki K, Kanagal-Shamanna R, Montalban-Bravo G, Assi R, Jabbour E, Ravandi F, Kadia T, Pierce S, Takahashi K, Nogueras Gonzalez G, Patel K, Soltysiak KA, Cortes J, Kantarjian HM, Garcia-Manero G.
    Cancer; 2020 Feb 15; 126(4):765-774. PubMed ID: 31742675
    [Abstract] [Full Text] [Related]

  • 3. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P, Dulau-Florea A, Calvo KR.
    Int J Lab Hematol; 2019 May 15; 41 Suppl 1():131-141. PubMed ID: 31069978
    [Abstract] [Full Text] [Related]

  • 4. Prognostic impact of DTA mutation and co-occurring mutations in patients with myelodysplastic syndrome.
    Wang M, Chen P, Li D, Zhao M.
    Mol Biol Rep; 2024 Sep 15; 51(1):985. PubMed ID: 39278886
    [Abstract] [Full Text] [Related]

  • 5. Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations.
    Lin TL, Nagata Y, Kao HW, Sanada M, Okuno Y, Huang CF, Liang DC, Kuo MC, Lai CL, Lee EH, Shih YS, Tanaka H, Shiraishi Y, Chiba K, Lin TH, Wu JH, Miyano S, Ogawa S, Shih LY.
    Haematologica; 2014 Jan 15; 99(1):28-36. PubMed ID: 23996483
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of TET2 mutations in myelodysplastic syndromes: A meta-analysis.
    Guo Z, Zhang SK, Zou Z, Fan RH, Lyu XD.
    Leuk Res; 2017 Jul 15; 58():102-107. PubMed ID: 28521175
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes.
    Jiang L, Luo Y, Zhu S, Wang L, Ma L, Zhang H, Shen C, Yang W, Ren Y, Zhou X, Mei C, Ye L, Xu W, Yang H, Lu C, Jin J, Tong H.
    Cancer Sci; 2020 Feb 15; 111(2):580-591. PubMed ID: 31804030
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decreased CD177pos neutrophils in myeloid neoplasms is associated with NPM1, RUNX1, TET2, and U2AF1 S34F mutations.
    Alayed K, Meyerson HJ.
    Leuk Res; 2022 Jan 15; 112():106752. PubMed ID: 34896936
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study.
    Cargo C, Bernard E, Beinortas T, Bolton KL, Glover P, Warren H, Payne D, Ali R, Khan A, Short M, Van Hoppe S, Smith A, Taylor J, Evans P, Papaemmanuil E, Crouch S.
    Lancet Haematol; 2024 Jan 15; 11(1):e51-e61. PubMed ID: 38135373
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation.
    Wang K, Zhou F, Cai X, Chao H, Zhang R, Chen S.
    Hematology; 2020 Dec 15; 25(1):211-218. PubMed ID: 32476595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.